Polomar Health Services, INC

Polomar Health Services, Inc. announced the appointment of Douglas Beck as Chief Financial Officer and Treasurer, effective July 15, 2026.

Polomar Health Services, Inc. has dismissed GreenGrowth CPAs and appointed Haskell & White LLP as its new independent registered public accounting firm.

Polomar Health Services, Inc. announced a significant restructuring of its Board of Directors and the appointment of new executive officers, effective July 1, 2026.

Polomar Health Services, Inc. has mutually agreed with Altanine, Inc. to terminate their previously announced merger agreement, citing that the transaction is no longer in the best interests of shareholders.

Polomar Health Services has waived several closing conditions for its merger with Altanine, Inc. and amended its CEO's employment agreement.

Polomar Health Services received notice of intent to terminate a material distribution and marketing agreement with ForHumanity, Inc., citing alleged false representations.

Polomar Health Services reports a significant revenue increase in Q1 2026 driven by a business model shift, though the company continues to face challenges and substantial doubt about its going concern status.

Polomar Health Services reported a significant increase in net losses and a substantial decline in revenue, raising concerns about its ability to continue operations.

Polomar Health Services, Inc. reported a significant increase in net loss and continued going concern doubts for the six months ended June 30, 2025, despite strategic shifts and new product initiatives.

Polomar Health Services, Inc. reported a significant increase in net loss and continued reliance on related-party financing for the quarter ended March 31, 2025, raising substantial doubt about its ability to continue as a going concern.

Polomar Health Services files an amended quarterly report (Form 10-Q/A) to address SEC comments, primarily concerning net loss per share calculations, fair market value assessment of acquired assets, revenue recognition policy expansion, and a change in accounting treatment for the Polomar Specialty Pharmacy acquisition.

Polomar Health Services, formerly Trustfeed Corp., completed a reverse merger with Polomar Specialty Pharmacy and reported its financial results for the quarter ended September 30, 2024.

Polomar Health Services' annual report highlights a strategic shift towards specialty pharmacy operations following a merger, while addressing financial challenges and future growth plans.

Trustfeed Corp. reports its 2023 financial results, marked by a significant change in control and a strategic shift away from its pre-existing business.

Polomar Health Services President Terrence Tierney reported acquisitions of 141,028 common shares occurring in mid-2025.

Trustfeed Corp. announces plans for a name change to Polomar Health Services, Inc., a reverse stock split, and the adoption of a new equity incentive plan, following a merger agreement with Polomar Specialty Pharmacy, LLC.

Polomar Health Services, Inc. filed an amendment to its S-1 registration statement, detailing offering expenses, indemnification policies, and recent unregistered stock issuances.

Polomar Health Services, a compounding pharmacy, reported significant losses and negative working capital as it transitions its business model and pursues a merger with Altanine Inc., which is expected to give Altanine shareholders 80% ownership of the combined entity.

Polomar Health Services, a development-stage compounding pharmacy, filed an S-1 registration statement detailing executive employment, a significant merger, and ongoing financial challenges.